Aug 1, 2011
Current Opinion in Endocrinology, Diabetes and Obesity
May 1, 2011
Journal of Autoimmunity
Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis
May 1, 2011
Cellular & Molecular Immunology
Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?
May 1, 2011
European Journal of Immunology
TLR2 signaling improves immunoregulation to prevent type 1 diabetes
Apr 1, 2011
Journal of Experimental Medicine
Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay
Mar 1, 2011
Clinical and Experimental Immunology
Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model
Feb 1, 2011
Science Translational Medicine
Humanizing animal models: a key to autoimmune diabetes treatement
Jan 1, 2011
Human Vaccines
Type 1 diabetes vaccine development: animal models vs. humans
Jan 1, 2011
Expert Review of Clinical Immunology
Protection against or triggering of Type 1 diabetes? Different roles for viral infections
Jan 1, 2011
Seminars in Immunopathology